Biogenic Carbon Quantum Dots: Synthesis and Applications.

The new class of nanomaterials termed carbon dots: a quasi-spherical nanoparticle having a size less than 10 nm, possesses some unique characteristics like good aqueous solubility, colloidal stability, resistance to photobleaching, and fluorescence tunability, resulting in the unfolding of their various properties and their usage in different applications. Materials that are naturally derived or produced by living organisms are termed 'biogenic'. Over the past few years, there has been a gradual increase in the use of naturally derived materials in synthesizing carbon dots. Green precursors or biogenic materials are of low cost, readily available, renewable, and environmentally benign. Most importantly, they provide essential benefits not found in synthesized carbon dots. This review focuses on the use of biogenic materials for the synthesis of biogenic carbon dots developed in the past five years. It also briefly explains different synthetic protocols used, along with some significant findings. Thereafter, an overview of the use of biogenic carbon dots (BCDs) in different applications like chemo and biosensors, drug delivery, bioimaging, catalysis and energy applications, etc., is discussed. Thus biogenic carbon dots are future sustainable materials that are now fast replacing conventional carbon quantum prepared from other sources.

Biogenic carbon dot-based fluorescence-mediated immunosensor for the detection of disease biomarker.

The dynamic interplay of nanotechnology and immunoassay has unlocked an arena for developing next-generation techniques to contribute to detecting disease biomarkers. Herein, the work establishes the strategic fabrication of an immunosensor by sandwich technique based on the fluorescence phenomenon of carbon dots for the detection of the disease biomarker VEGF (Vascular Endothelial Growth Factor). VEGF, a biomarker for angiogenesis, is considered cancerous if found in elevated levels in the blood, and so is paramount for early detection of disease. Carbon dots derived from a biogenic source were synthesized employing a green microwave-assisted method followed by conjugating with a detection antibody, human immunoglobulin G (IgG), via EDC-NHS amidation reaction. On the other hand, the VEGF biomarker was immobilized onto the capture antibody. The detection antibody tagged with the fluorescent probe is employed as a bridge to connect with the VEGF biomarkers bound to the capture antibody. The response to different concentrations of VEGF biomarkers was recorded in terms of the fluorescence intensity of the carbon dots. The fluorescence immunosensor could exhibit a wide linear range of 0.1 fg/mL to 10 pg/mL with a low detection limit of 5.65 pg/mL towards VEGF. The potentiality of this designed immunosensor was qualitatively assessed with human blood plasma samples, showing promising results, thereby upholding the applicability of carbon dots as fluorescent labels in immunoassay techniques.

Resistin: A journey from metabolism to cancer.

Resistin, a small secretory molecule, has been implicated to play an important role in the development of insulin resistance under obese condition. For the past few decades, it has been linked to various cellular and metabolic functions. It has been associated with diseases like metabolic disorders, cardiovascular diseases and cancers. Numerous clinical studies have indicated an increased serum resistin level in pathological disorders which have been reported to increase mortality rate in comparison to low resistin expressing subjects. Various molecular studies suggest resistin plays a pivotal role in proliferation, metastasis, angiogenesis, inflammation as well as in regulating metabolism in cancer cells. Therefore, understanding the role of resistin and elucidating its' associated molecular mechanism will give a better insight into the management of these disorders. In this article, we summarize the diverse roles of resistin in pathological disorders based on the available literature, clinicopathological data, and a compiled study from various databases. The article mainly provides comprehensive information of its role as a target in different treatment modalities in pre as well as post-clinical studies.

Metformin induced lactic acidosis impaired response of cancer cells towards paclitaxel and doxorubicin: Role of monocarboxylate transporter.

Abnormal glucose metabolism in cancer cells causes generation and secretion of excess lactate, which results in acidification of the extracellular microenvironment. This altered metabolism aids not only in survival and proliferation but also in suppressing immune-mediated destruction of cancer cells. However, how it influences the response of cancer cells to chemotherapeutic drugs is not clearly understood. We employed appropriate in vitro approaches to explore the role of mono-carboxylate transporter 4 (MCT4) mediated altered intra and extracellular pH on the outcome of the therapeutic efficacy of chemotherapeutic drugs in breast and lung cancer models. We demonstrate by in vitro experiments that inhibition of complex I enhances glycolysis and increases expression as well as membrane translocation of MCT4. It causes a decrease in extracellular pH (pHe) and impairs doxorubicin and paclitaxel's therapeutic efficacy. Acidic pHe inhibits doxorubicin's uptake, while acidic intracellular pH (pH i) impairs the efficacy of paclitaxel. Under in vivo experimental settings, the modulation of pHe with phloretin or alkalizer (NaHCO3) enhances cytotoxicity of drugs and inhibits the growth of MCF-7 xenografts in mice. In a nutshell, this study indicates that MCT4 mediated extracellular acidosis is involved in impairing chemotherapeutic drugs' efficacy on cancer cells. Therefore, the use of pH neutralizing agents or MCT inhibitors may be beneficial towards circumventing impairment in the efficacy of certain drugs that are sensitive to pH changes.

Nano-Bioconjugate Film from Aloe vera To Detect Hazardous Chemicals Used in Cosmetics.

It is of utmost importance to detect hazardous chemicals that affect human health. In this work, a simple method has been developed using a traditional medicinal herb Aloe vera as a carbon source to fabricate a nano-bioconjugate film. The nano-bioconjugate system comprises of A. vera gel itself and sodium alginate to form a fluorescent nano-bioconjugate film. The film was successfully used as an optical "turn-off" sensor in detecting analytes viz. para-Aminobenzoic acid (PABA), benzophenone, hydroquinone, and propylparaben, which are used in cosmetics and are listed as "red-listed" chemicals. The applicability of the fluorescent film in detecting these hazardous chemicals was even assessed with some locally purchased cosmetic samples. Mechanistic insight into the fluorescent quenching shown by nano-bioconjugate film is also discussed. Developments of such a detection system from sustainable sources make it an interesting option for fabricating sensors for hazardous chemicals.

Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality.

Cancer and diabetes are amongst the leading causes of deaths worldwide. There is an alarming rise in cancer incidences and mortality, with approximately 18.1 million new cases and 9.6 million deaths in 2018. A major contributory but neglected factor for risk of neoplastic transformation is hyperglycemia. Epidemiologically too, lifestyle patterns resulting in high blood glucose level, with or without the role of insulin, are more often correlated with cancer risk, progression, and mortality. The two conditions recurrently exist in comorbidity, and their interplay has rendered treatment regimens more challenging by restricting the choice of drugs, affecting surgical consequences, and having associated fatal complications. Limited comprehensive literature is available on their correlation, and a lack of clarity in understanding in such comorbid conditions contributes to higher mortality rates. Hence, a critical analysis of the elements responsible for enhanced mortality due to hyperglycemia-cancer concomitance is warranted. Given the lifestyle changes in the human population, increasing metabolic disorders, and glucose addiction of cancer cells, hyperglycemia related complications in cancer underline the necessity for further in-depth investigations. This review, therefore, attempts to shed light upon hyperglycemia associated factors in the risk, progression, mortality, and treatment of cancer to highlight important mechanisms and potential therapeutic targets.

Dual emission carbon dots from carotenoids: Converting a single emission to dual emission.

Dual emission carbon dots have a high potential for use as fluorescence-based sensors with higher selectivity and sensitivity. This study demonstrated the possibility of conversion of a biological molecular system with a single emission peak to a double emission carbon dots system. This report is the first to describe the synthesis of dual emission carbon dots by tuning the electronic environment of a conjugated system. Here we prepared carbon dots from a natural extract, from which carotenoids were used as a new source for carbon dots. Formation of the carbon dots was confirmed by images obtained under a transmission electron microscope as well as from a dynamic light scattering study. The prepared carbon dots system was characterized and its optical property was monitored. The study showed that, after irradiation with microwaves, the fluorescence intensity of the whole system changed, without any change in the original peak position of the carotenoid but with the appearance of an additional peak. A Fourier transform infrared study confirmed breaking of the conjugated system. When using ethylene glycol as a surface passivating agent added to these carotenoid carbon dots, the dual emission spectra became more distinct.